Jervan Ø, Haukeland-Parker S, Gleditsch J, Tavoly M, Klok FA, Steine K, Johannessen HH, Spruit MA, Atar D, Holst R, Dahm AEA, Sirnes PA, Stavem K, Ghanima W(2023) The effects of exercise training in patients with persistent dyspnoea after pulmonary embolism: a randomized controlled trial Chest(in press) DOI 10.1016/j.chest.2023.04.042, PubMed 37149257
Terpos E, Musto P, Engelhardt M, Delforge M, Cook G, Gay F, van de Donk NWCJ, Ntanasis-Stathopoulos I, Vangsted AJ, Driessen C, Schjesvold F, Cerchione C, Zweegman S, Hajek R, Moreau P, Einsele H, San-Miguel J, Boccadoro M, Dimopoulos MA, Sonneveld P, Ludwig H(2023) Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN) Leukemia, 1-11(in press) DOI 10.1038/s41375-023-01920-1, PubMed 37142661
Geelen IGP, Gullaksen SE, Ilander MM, Olssen-Strömberg U, Mustjoki S, Richter J, Blijlevens NMA, Smit WM, Gjertsen BT, Gedde-Dahl T, Markevärn B, Koppes MMA, Westerweel PE, Hjorth-Hansen H, Janssen JJWM(2023) Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects Ann Hematol, 102(6), 1395-1408 DOI 10.1007/s00277-023-05199-1, PubMed 37119314